G9147 – Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration

Long description

Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration

Short description

Outpt iv insulin tx any mea

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

M Non-covered by Medicare

BETOS category

P5E Ambulatory procedures - other

Added

December 23, 2009

Last change

December 23, 2009 – No change

Nearby G codes

• G9134 – Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)
• G9135 – Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)
• G9136 – Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)
• G9137 – Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)
• G9138 – Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)
• G9139 – Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)
• G9140 – Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours
• G9143 – Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)
• G9148 – National committee for quality assurance - level 1 medical home
• G9149 – National committee for quality assurance - level 2 medical home
• G9150 – National committee for quality assurance - level 3 medical home
• G9151 – Mapcp demonstration - state provided services
• G9152 – Mapcp demonstration - community health teams
• G9153 – Mapcp demonstration - physician incentive pool
• G9156 – Evaluation for wheelchair requiring face to face visit with physician
• G9157 – Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes